Dynavax (DVAX) Tops Q3 EPS by 5c

Dynavax (NASDAQ: DVAX) reported Q3 EPS of ($0.70), $0.05 better than the analyst estimate of ($0.75). Revenue for the quarter came in at $685 thousand versus the consensus estimate of $1.15 million.

For earnings history and earnings-related data on Dynavax (DVAX) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• OneMain (OMF) Reiterated at Market Outperform by Citizens on Updated Estimates
• Wintermar acquires full control of Fast Offshore Supply, adding 5 new CTVs